All Stories

  1. Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A

    Article • Applied Microbiology and Biotechnology, January 2015, Springer Science + Business Media

    Dr José L Corchero

  2. Recombinant protein materials for bioengineering and nanomedicine

    Article • Nanomedicine, December 2014, Future Medicine

    Dr José L Corchero

  3. General Introduction: Recombinant Protein Production and Purification of Insoluble Proteins

    Article • November 2014, Springer Science + Business Media

    Dr José L Corchero

  4. In Vivo Architectonic Stability of Fully de Novo Designed Protein-Only Nanoparticles

    Article • ACS Nano, May 2014, American Chemical Society (ACS)

    Dr José L Corchero

  5. Biomedical Applications of Bacterial Inclusion Bodies

    Article • April 2014, Wiley

    Dr José L Corchero

  6. Sheltering DNA in self-organizing, protein-only nano-shells as artificial viruses for gene delivery

    Article • Nanomedicine Nanotechnology Biology and Medicine, April 2014, Elsevier

    Dr José L Corchero

  7. Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy

    Article • Critical Reviews in Biotechnology, October 2013, Taylor & Francis

    Dr José L Corchero

  8. A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs

    Article • Nanomedicine, October 2013, Future Medicine

    Dr José L Corchero, Mr Karl Peebo

  9. Multifunctional Nanovesicle-Bioactive Conjugates Prepared by a One-Step Scalable Method Using CO 2 -Expanded Solvents

    Article • Nano Letters, August 2013, American Chemical Society (ACS)

    Dr José L Corchero

  10. Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies

    Article • Acta Biomaterialia, April 2013, Elsevier

    Dr José L Corchero, Rafael Cubarsi

  11. Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics

    Article • Biotechnology Advances, March 2013, Elsevier

    Dr José L Corchero

  12. Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles

    Article • International Journal of Nanomedicine, August 2012, Taylor & Francis

    Dr José L Corchero

  13. Enzymatic characterization of highly stable human alpha-galactosidase A displayed on magnetic particles

    Article • Biochemical Engineering Journal, August 2012, Elsevier

    Dr José L Corchero

  14. Nanopills: Functional Inclusion Bodies Produced in Bacteria as Naturally Occurring Nanopills for Advanced Cell Therapies (Adv. Mater. 13/2012)

    Article • Advanced Materials, March 2012, Wiley

    Dr José L Corchero

  15. Functional Inclusion Bodies Produced in Bacteria as Naturally Occurring Nanopills for Advanced Cell Therapies

    Article • Advanced Materials, March 2012, Wiley

    Dr José L Corchero

  16. Bacterial inclusion bodies: making gold from waste

    Article • Trends in Biotechnology, February 2012, Elsevier

    Dr José L Corchero

  17. Packaging protein drugs as bacterial inclusion bodies for therapeutic applications

    Article • Microbial Cell Factories, January 2012, Springer Science + Business Media

    Dr José L Corchero

  18. Integrated approach to produce a recombinant, his-tagged human α-galactosidase a in mammalian cells

    Article • Biotechnology Progress, May 2011, Wiley

    Dr José L Corchero, PhD Julia Lorenzo

  19. Self-assembling, protein-based intracellular bacterial organelles: emerging vehicles for encapsulating, targeting and delivering therapeutical cargoes

    Article • Microbial Cell Factories, January 2011, Springer Science + Business Media

    Dr José L Corchero

  20. Post-production protein stability: trouble beyond the cell factory

    Article • Microbial Cell Factories, January 2011, Springer Science + Business Media

    Dr José L Corchero

  21. Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine

    Article • Microbial Cell Factories, January 2011, Springer Science + Business Media

    Dr José L Corchero

  22. Properties of Human Alpha-galactosidase A Immobilized on Different-sized Magnetic Particles through Different Methods

    Article • Journal of Biotechnology, November 2010, Elsevier

    Dr José L Corchero

  23. Integrated Approach to Optimize Transient Gene Expression in Mammalian Cells: Production of a Recombinant Human Alpha-galactosidase A

    Article • Journal of Biotechnology, November 2010, Elsevier

    Dr José L Corchero, PhD Julia Lorenzo

  24. Recombinant production of a difficult-to-express eukaryotic protein in a bacterial expression system

    Article • New Biotechnology, September 2009, Elsevier

    Dr José L Corchero

  25. Bacterial inclusion bodies as novel functional and biocompatible nanomaterials

    Article • New Biotechnology, September 2009, Elsevier

    Dr José L Corchero

  26. Biomedical applications of distally controlled magnetic nanoparticles

    Article • Trends in Biotechnology, August 2009, Elsevier

    Dr José L Corchero

  27. Surface Cell Growth Engineering Assisted by a Novel Bacterial Nanomaterial

    Article • Advanced Materials, June 2009, Wiley

    Dr José L Corchero

  28. Modular Protein Engineering in Emerging Cancer Therapies

    Article • Current Pharmaceutical Design, March 2009, Bentham Science Publishers

    Dr José L Corchero

  29. Microbial factories for recombinant pharmaceuticals

    Article • Microbial Cell Factories, January 2009, Springer Science + Business Media

    Dr José L Corchero

  30. Control of Escherichia coli growth rate through cell density

    Article • Microbiological Research, January 2002, Elsevier

    Dr José L Corchero

  31. Comparison of Serologic Assays for Detection of Antibodies against Human Herpesvirus 8

    Article • Clinical and Diagnostic Laboratory Immunology, September 2001, ASM Journals

    Professor Naoki Inoue, Dr José L Corchero

  32. Cell lysis in Escherichia coli cultures stimulates growth and biosynthesis of recombinant proteins in surviving cells

    Article • Microbiological Research, January 2001, Elsevier

    Dr José L Corchero

  33. Tolerance ofEscherichia coli ?-galactosidase C-terminus to different-sized fusions

    Article • Biotechnology and Bioengineering, September 1999, Wiley

    Dr José L Corchero

  34. Proteolytic digestion of bacterial inclusion body proteins during dynamic transition between soluble and insoluble forms

    Article • Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, September 1999, Elsevier

    Dr José L Corchero

  35. Heat-inactivation of plasmid-encoded CI857 repressor induces gene expression from Ind − lambda prophage in recombinant Escherichia coli

    Article • FEMS Microbiology Letters, August 1999, Oxford University Press (OUP)

    Dr José L Corchero

  36. The expression of recombinant genes from bacteriophage lambda strong promoters triggers the SOS response inEscherichia coli

    Article • Biotechnology and Bioengineering, July 1999, Wiley

    Dr José L Corchero

  37. The expression of recombinant genes from bacteriophage lambda strong promoters triggers the SOS response in Escherichia coli

    Article • Biotechnology and Bioengineering, July 1999, Wiley

    Dr José L Corchero

  38. The expression of recombinant genes from bacteriophage lambda strong promoters triggers the SOS response inEscherichia coli

    Article • Biotechnology and Bioengineering, December 1998, Wiley

    Dr José L Corchero

  39. Dynamics of in vivo protein aggregation: building inclusion bodies in recombinant bacteria

    Article • FEMS Microbiology Letters, December 1998, Oxford University Press (OUP)

    Dr José L Corchero

  40. Plasmid maintenance in Escherichia coli recombinant cultures is dramatically, steadily, and specifically influenced by features of the encoded proteins

    Article • Biotechnology and Bioengineering, June 1998, Wiley

    Dr José L Corchero

  41. Plasmid maintenance inEscherichia coli recombinant cultures is dramatically, steadily, and specifically influenced by features of the encoded proteins

    Article • Biotechnology and Bioengineering, June 1998, Wiley

    Dr José L Corchero

  42. Reversible activation of a cryptic cleavage site within E. coli β-galactosidase in β-galactosidase fusion proteins

    Article • Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, December 1997, Elsevier

    Dr José L Corchero

  43. Antigenicity of a viral peptide displayed on β-galactosidase fusion proteins is influenced by the presence of the homologous partner protein

    Article • FEMS Microbiology Letters, November 1996, Oxford University Press (OUP)

    Dr José L Corchero

  44. Antigenicity of a viral peptide displayed on β-galactosidase fusion proteins is influenced by the presence of the homologous partner protein

    Article • FEMS Microbiology Letters, November 1996, Oxford University Press (OUP)

    Dr José L Corchero

  45. The position of the heterologous domain can influence the solubility and proteolysis of β-galactosidase fusion proteins in E. coli

    Article • Journal of Biotechnology, July 1996, Elsevier

    Dr José L Corchero

  46. A recombinant foot-and-mouth disease virus antigen inhibits DNA replication and triggers the SOS response in

    Article • FEMS Microbiology Letters, June 1995, Oxford University Press (OUP)

    Dr José L Corchero

  47. A recombinant foot-and-mouth disease virus antigen inhibits DNA replication and triggers the SOS response in Escherichia coli

    Article • FEMS Microbiology Letters, June 1995, Oxford University Press (OUP)

    Dr José L Corchero

  48. Mitomycin C stimulates thermally induced recombinant gene expression in Escherichia coli MC strains

    Article • Applied Microbiology and Biotechnology, March 1995, Springer Science + Business Media

    Dr José L Corchero

  49. Ammonium-Mediated Reduction of Plasmid Copy Number and Recombinant Gene Expression in Escherichia coli

    Article • Biotechnology Progress, November 1994, Wiley

    Dr José L Corchero

  50. Production of thermally induced recombinant proteins relative to cell biomass is influenced by cell density in Escherichia coli batch cultures

    Article • Biotechnology Letters, August 1994, Springer Science + Business Media

    Dr José L Corchero